<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Objective: To assess the relationship of serum osteocalcin levels with blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:chebi fb="23" ids="18059">lipid</z:chebi> profile in central Indian men with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Methods: Anthropometric and biochemical parameters were measured in 56 newly diagnosed type 2 diabetic men and in 56 age and body mass index (BMI) matched controls </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> was calculated by homeostasis model assessment of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (HOMA-IR) </plain></SENT>
<SENT sid="3" pm="."><plain>Results: After adjustment for age and BMI, osteocalcin levels were negatively correlated with fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (p = 0.0004), fasting insulin (p = 0.0311), HOMA-IR (p = 0.0023), and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (p = 0.0095), and positively correlated with <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>)-cholesterol (p = 0.0042) in type 2 diabetic patients </plain></SENT>
<SENT sid="4" pm="."><plain>In multivariate logistic regression analyses that adjusted for age, BMI, waist circumference and waist-to-hip ratio, osteocalcin was inversely associated with the presence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (p &lt; 0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>Conclusion: Osteocalcin may play a protective role in the pathogenesis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, not only through direct involvement in <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis, but also through improving <z:chebi fb="23" ids="18059">lipid</z:chebi> profile </plain></SENT>
</text></document>